PrescIT平台:一个可互操作的临床决策支持系统,用于电子处方,以预防不良药反应和药物相互作用
Pantelis Natsiavas1, George Nikolaidis2, Jenny Pliatsika3
1Institute of Applied Biosciences, Centre for Research and Technology Hellas, 6th Km. Charilaou, Thermi Road, Thermi, PO Box 60361, 57001, Thessaloniki, Greece. pnatsiavas@certh.gr.
Drug safety
|July 19, 2024
概括
临床决策支持系统 (CDSS) PrescIT平台通过防止电子处方期间的不良药物反应和相互作用来减少药物错误. 希腊医院的试点测试表明其有用性,尽管建议改进可用性.
科学领域:
- 医疗信息学 医疗信息学
- 临床决策支持系统 临床决策支持系统
- 药物监督 药物监督 药物监督
背景情况:
- 可预防的药物错误对公众健康构成重大风险.
- 电子处方 (ePrescription) 为预防药物错误和不良反应提供了一个关键的机会.
- 集成到信息系统中的智能计算方法可以显著减少临床实践中的这些错误.
研究的目的:
- 在希腊引入PrescIT平台,一个旨在预防药物不良反应 (ADR) 和药物相互作用 (DDI) 的临床决策支持系统 (CDSS).
- 评估平台的本地化和适应其他医疗保健环境的潜力.
- 提高药物处方过程的安全性和效率.
主要方法:
- 使用知识工程 (KE) 方法开发PrescIT平台,包括本体论和知识图 (KG).
- 利用开放标准 (RDF,OWL,SPARQL) 实现互操作性和与现有IT系统或独立使用的集成.
- 使用诸如DrugBank,MedDRA,SemMedDB和OpenPVSignal等数据源,以及BPMN用于治疗协议.
- 在三家医院的18名临床专业人员进行试点测试,使用大声思考课程.
主要成果:
- 成功将PrescIT平台集成到专有医院信息系统 (HIS) 和希腊国家电子处方系统中.
- 证明了作为独立应用程序的功能能力.
- 试点阶段的反表明,用户普遍承认该系统的有用性,并确定了可用性和用户体验方面的挑战.
- 验证平台在现实环境中支持更安全的药物处方的能力.
结论:
- 在临床环境中,PrescIT平台已成功部署和试点运行.
- 该系统展示了通过在电子处方期间的智能支持来提高药物安全的潜力.
- 建议根据用户反进行进一步的改进,以优化可用性和用户体验.
相关概念视频
01:19Pharmacovigilance
813
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
813
01:27Nursing Clinical Information System
765
Nursing Clinical Information System (NCIS)
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
765
01:25Antidepressant Drugs: Overview
425
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
425
01:28Structure-Activity Relationships and Drug Design
697
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
697
01:26Drug Administration and Therapy Phases: Overview
444
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
444
01:29Drug-Receptor Interactions
5.1K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.1K